PRLD — Prelude Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Prelude Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	218	291	202	233	134
Prepaid Expenses
Total Current Assets	221	295	204	236	136
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	2.48	5.64	6.7	37.7	35.5
Other Long Term Assets
Total Assets	224	305	221	278	176
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.4	19.2	21.7	21.8	25.6
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	11.4	19.2	25.1	40.6	44.1
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	212	286	195	237	131
Total Liabilities & Shareholders' Equity	224	305	221	278	176
Total Common Shares Outstanding